Oncotelic
Press Releases
All press releases, organized by date
Corporate Videos
Oncotelic; Announcing Successful Joint Venture and Diving into Benefits for Shareholders
Oncotelic presentation at MedInvest Pharmaceutical & Biotechnology Investor Conference
Oncotelic; Discussing the Company’s Verticals and Paths to Revenue
Oncotelic; Looking at Industry Comparison for the Company
Oncotelic; Discussing the Company’s Development Pipeline
Oncotelic; Diving into the Company’s Outlook for 2022
Oncotelic; An Introduction to CFO Amit Shah & His Industry Background
Oncotelic; An Introduction to Chief Clinical Officer Anthony Maida & His Background
Oncotelic; An Introduction to CBO GM of AI Division Saran Saund
About Sapu Nano
Precision Nanomedicine · Sub-20nm Deciparticle™ Platform · Global Development
Sapu Nano develops sub-20nm Deciparticle™ therapeutics engineered for deeper tumor penetration, improved biodistribution, and optimized systemic exposure. Our platform supports next-generation oncology medicines, with programs advancing through early- and late-stage clinical development across solid tumors and rare pediatric diseases.
IMPORTANT LINKS
Our Office
Sapu Nano
10801 Thornmint Rd. Suite 150
San Diego, CA 92127
Phone: (858) 521-8037
info@sapunano.com